Add to ORKGThis invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) using the leading flavone compound acacetin, and its derivatives and analogues that inhibit the ultra-rapidly-activating delayed rectifier potassium current (IKur or IKsus), transient outward potassium (Ito), and acetylcholine-activated potassium current (IKAch).published_or_final_versio
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
Atrial Fibrillation (AF) is one of the most common forms of cardiac arrhythmia and affects a large p...
The acetylcholine-activated inward rectifier potassium current (IKACh) is constitutively active in p...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This journal issue is proceedings of ICSM 2010Abstracts for Oral CommunicationsWe have recently demo...
Oral Presentations: S23 Session - Molecular Cardiology, Basic Research: abstract O93We have recentl...
BACKGROUND - The development of atrium-selective antiarrhythmic agents is a current strategy for inh...
Poster presentationBackground and objective: We have recently demonstrated that the natural flavone ...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
The natural flavones and polymethylflavone have been reported to have cardiovascular protective effe...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
Atrial Fibrillation (AF) is one of the most common forms of cardiac arrhythmia and affects a large p...
The acetylcholine-activated inward rectifier potassium current (IKACh) is constitutively active in p...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This journal issue is proceedings of ICSM 2010Abstracts for Oral CommunicationsWe have recently demo...
Oral Presentations: S23 Session - Molecular Cardiology, Basic Research: abstract O93We have recentl...
BACKGROUND - The development of atrium-selective antiarrhythmic agents is a current strategy for inh...
Poster presentationBackground and objective: We have recently demonstrated that the natural flavone ...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
The natural flavones and polymethylflavone have been reported to have cardiovascular protective effe...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
Atrial Fibrillation (AF) is one of the most common forms of cardiac arrhythmia and affects a large p...
The acetylcholine-activated inward rectifier potassium current (IKACh) is constitutively active in p...